Phase 1 study of chidamide in combination with venetoclax, azacitidine, aclarubicin, cytarabine and G-CSF for refractory/relapsed acute myeloid leukemia: clinical safety, efficacy, and correlative analysis
一项评估西达米德联合维奈托克、阿扎胞苷、阿克拉霉素、阿糖胞苷和粒细胞集落刺激因子治疗难治性/复发性急性髓系白血病的I期临床研究:临床安全性、有效性和相关性分析
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1698710
Wen, Yanan; Yang, Jingjing; Zhang, Xiawei; Liu, Qingyang; Gao, Wenjing; Dong, Lili; Zhao, Weijia; Huang, Sai; Liu, Daihong; Jing, Yu; Dou, Liping